Next Issue
Volume 13, 08
Previous Issue
Volume 13, 05
 
 
cardiovascmed-logo

Journal Browser

Journal Browser
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).

Cardiovasc. Med., Volume 13, Issue 6 (06 2010) – 6 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
5 pages, 120 KB  
Editorial
Medikamenten-freisetzende Ballonkatheter (Drug-Eluting Balloons) in der Behandlung der Koronaren Herzkrankheit
by Thomas Pilgrim, Marco Roffi, Giovanni Pedrazzini, Christoph Kaiser, Jean-Christoph Stauffer, Hans Rickli and Stephan Windecker
Cardiovasc. Med. 2010, 13(6), 214; https://doi.org/10.4414/cvm.2010.01505 - 30 Jun 2010
Viewed by 10
Abstract
Drug-eluting balloons use paclitaxel as active substance on account of its high absorption rate, rapid assimilation by the intima and long-lasting effect. Clinical studies have investigated the safety and effectiveness of drug-eluting balloons in various clinical scenarios and support the use of paclitaxel-eluting [...] Read more.
Drug-eluting balloons use paclitaxel as active substance on account of its high absorption rate, rapid assimilation by the intima and long-lasting effect. Clinical studies have investigated the safety and effectiveness of drug-eluting balloons in various clinical scenarios and support the use of paclitaxel-eluting balloons for the treatment of in-stent restenoses with a reference- vessel diameter of ≥2.5 mm. However, current evidence does not warrant treating first-time stenoses and bifurcation lesions with drug-eluting balloon catheters. Full article
6 pages, 187 KB  
Article
Noninvasive Hemodynamic Monitoring by Transthoracic Impedance Cardiography During Different Ventricular Activation Sequences in CRT Patients
by David Altmann, Beat Schaer, Robert Blank, Raban Jeger, Christian Sticherling and Stefan Osswald
Cardiovasc. Med. 2010, 13(6), 208; https://doi.org/10.4414/cvm.2010.01506 - 30 Jun 2010
Viewed by 15
Abstract
Background: Echocardiography-based programming of conduction delays in cardiac resynchronisation therapy is complex and time-consuming. Impedance cardiography (ICG) may be an alternative method. However, it is unknown whether ICG is sensitive enough to detect haemodynamic changes due to different pacing-induced ventricular activation modes. The [...] Read more.
Background: Echocardiography-based programming of conduction delays in cardiac resynchronisation therapy is complex and time-consuming. Impedance cardiography (ICG) may be an alternative method. However, it is unknown whether ICG is sensitive enough to detect haemodynamic changes due to different pacing-induced ventricular activation modes. The aim of this study was to determine the ability of ICG to measure haemodynamic changes during different ventricular pacing modes in patients with a cardiac resynchronisation therapy (CRT). Methods: 18 patients were evaluated. Stroke volume (SV), cardiac output (CO) and total peripheral resistance (TPR) were measured by means of ICG. Continuous blood pressure (cBP) was recorded with the vascular unloading technique. Haemodynamic measurements of 10-minute-sampling periods, taken in the supine position, were compared during biventricular (BIV), right (RV) and left ventricular (LV) pacing and intrinsic rhythm (IR). Results: One patient was excluded from the analysis (serious haemodynamic deterioration during IR). The age of the study population was 67 ± 10 years (94% male) with a LV ejection fraction of 26 ± 6%. The majority had left-bundle-branch block (82%). Compared to IR, BIV increased SV (58 ± 11 vs 67 ± 12 ml; p = 0.0007), CO (3.6 ± 0.7 vs 4.2 ± 0.8 l/min; p = 0.0007) and reduced TPR (1975 ± 410 vs 1694 ± 390 dyn*s/cm5). cBP remained unchanged during different ventricular pacing modes. Conclusion: ICG is able to detect intraindividual changes of haemodynamic parameters induced by different pacing modes. However, its sensitivity to detect haemodynamic changes through conduction delay variations, as performed for device optimisation, remains unclear. Full article
4 pages, 105 KB  
Article
Natural History of Aortic Stenosis
by Fredi Bärtschi, Michel Zuber, Mehdi Namdar, Burkart Seifert and Rolf Jenni
Cardiovasc. Med. 2010, 13(6), 204; https://doi.org/10.4414/cvm.2010.01507 - 30 Jun 2010
Viewed by 10
Abstract
Background: Management of patients with aortic stenosis is challenging since only few data exists indicating the rate of progression and the correlation to relevant determinants. We investigated whether analysis of the long-term progression, etiology and vascular risk factors could help to define optimal [...] Read more.
Background: Management of patients with aortic stenosis is challenging since only few data exists indicating the rate of progression and the correlation to relevant determinants. We investigated whether analysis of the long-term progression, etiology and vascular risk factors could help to define optimal control intervals. Methods: We included 77 patients (age 51.1 ± 14.3 years) in one referral centre with an echocardiographyproven aortic stenosis (mean gradient >12 mm Hg) and a long-term follow-up of three echocardiographic examinations. Missing clinical data were supplemented by a questionnaire to the general practitioner. Two retrospective examination time intervals were defined as a second interval of <2 years (1.3 ± 0.4) and a first interval of >2 years (6.0 ± 2.4) dating back to the initial examination (maximum of 10.6 years prior to the last examination). Results: During 6.0 ± 2.4 years, the mean pressure gradient increased from 24.2 ± 13.6 to 38.1 ± 20.4 mm Hg (p <0.0001); respectively 2.1 ± 3.0 mm Hg/year in the first time period and 4.2 ± 8.2 mm Hg/year in the second time period (p = 0.049), for the entire population. According to severity, patients with mild or moderate aortic stenosis showed an increase from 2.0 ± 2.7 to 4.0 ± 6.6 mm Hg/year (p = 0.04) or from 2.2 ± 3.2 to 3.5 ± 10.9 mm Hg/year respectively (p = 0.66). The group with severe aortic stenosis had an increase of 9.6 ± 12.0 mm Hg/year (group too small for statistical analysis). During the total examination period, left ventricular mass index increased from 149 ± 60 g/m2 to 168 ± 63 g/m2 (p <0.0001), which corresponds to an increase of 3.2 to 7.8 g/m2 per annum (p = 0.52), and the relative wall thickness increased from 40.0 ± 8.5 to 43.0 ± 9.8% (p = 0.002). Ejection fraction remained stable and we found no correlation between etiology, vascular risk factors and progression of the disease. Conclusions: Progression of the mean pressure gradient in patients with aortic stenosis went from 2 mm Hg/year for mild stenosis, to 4 mm Hg/year for moderate stenosis. We found no correlation to conventional vascular risk factors. In patients with mild aortic stenosis and preserved left ventricular ejection fraction, echocardiographic follow-up every 3 to 5 years, until a mean transvalvular pressure gradient of 30 mm Hg is reached, might be a safe and cost-effective follow-up strategy. In patients with more severe aortic stenosis, follow-up has to be more frequent. Full article
7 pages, 810 KB  
Review
Aortenklappenersatz bei älteren Patienten mit Schwerer Aortenstenose
by Thomas Pilgrim and Peter Wenaweser
Cardiovasc. Med. 2010, 13(6), 197; https://doi.org/10.4414/cvm.2010.01510 - 30 Jun 2010
Cited by 1 | Viewed by 14
Abstract
Severe calcific aortic stenosis is a disease of the elderly and associated with reduced quality of life and adverse prognosis. According to demographic estimations the share of octogenarians will markedly increase in the course of the decades to come. As a consequence, the [...] Read more.
Severe calcific aortic stenosis is a disease of the elderly and associated with reduced quality of life and adverse prognosis. According to demographic estimations the share of octogenarians will markedly increase in the course of the decades to come. As a consequence, the incidence of symptomatic aortic stenosis will increase along with the need for minimally invasive treatment options. Since to date there is no efficacious medical treatment for aortic stenosis, elderly patients suffering from significant co-morbidities that portend an increased risk for surgery may benefit from a novel intervention with a minimally-invasive approach. Until this moment, seven years after the first successful transcatheter aortic valve implantation, transfemoral or transapical aortic valves have been implanted worldwide in approximately 10 000 patients. Clinical trials and early experience indicate that this minimally invasive intervention proves successful in >90%. Thirty-day mortality amounts to 10% and in case of a successful procedure a significant reduction of symptoms and an improvement of quality of life can be expected. Vascular access site complications and atrio-ventricular conduction disturbances are the most commonly observed adverse events. Full article
6 pages, 269 KB  
Review
New Combination Drugs in Lipid Management
by Walter F. Riesen and Giorgio Noseda
Cardiovasc. Med. 2010, 13(6), 191; https://doi.org/10.4414/cvm.2010.01509 - 30 Jun 2010
Viewed by 10
Abstract
Several epidemiological and clinical studies have shown that lower LDL cholesterol levels are associated with a lower incidence of coronary events. Given that doubling the statin dose only results in an additional, approximate 6% decrease in LDL cholesterol levels, high statin doses may [...] Read more.
Several epidemiological and clinical studies have shown that lower LDL cholesterol levels are associated with a lower incidence of coronary events. Given that doubling the statin dose only results in an additional, approximate 6% decrease in LDL cholesterol levels, high statin doses may be necessary to reach the target. Accordingly an increased risk for adverse effects by these very safe drugs at conventional doses has to be accepted. The combination of inhibition of synthesis by statin therapy with ezetimibe, a cholesterol absorption inhibitor, has been shown to be most efficacious in lowering LDL cholesterol. The clinical data on treatment with ezetimibe, although not entirely conclusive, suggest that lipid lowering with statin plus ezetimibe has comparable clinical effects to treatment with statin alone in high doses. However, even when lowering LDL cholesterol to very low levels, a considerable residual risk remains. Alternatively, low levels of HDL cholesterol may be treated as a secondary lipid target by combination with niacin, an efficient HDL cholesterol raising drug. This approach has led to significant reductions in the risk of a cardiovascular event and in stabilisation and regression of atherosclerosis in, generally, small clinical studies. Most recently, a comparative effectiveness trial comparing extended-release niacin with ezetimibe in patients on statin therapy for 6 years showed that extended-release niacin causes a significant regression of carotid intima-media thickness, while no regression was found with ezetimibe. Full article
6 pages, 482 KB  
Editorial
Der Arzt – ein Auslaufmodell?
by Thomas F. Lüscher
Cardiovasc. Med. 2010, 13(6), 185; https://doi.org/10.4414/cvm.2010.01508 - 30 Jun 2010
Cited by 1 | Viewed by 12
Abstract
«Ärzte […] sind nicht mehr als Hauptakteure staatlicher Gesundheitsfürsorge gefragt, sondern werden als abhängige Mitwirkende im grossen wirtschaftlichen Verteilspiel eingesetzt.» Paul U. Unschuld 2005 [1] Full article
Previous Issue
Next Issue
Back to TopTop